newscientist.com

Unapproved gene therapy for boosting longevity is set to go on sale | New Scientist

A gene therapy that instructs cells to produce more of an anti-ageing protein called klotho is about to be offered by a US company at overseas clinics to bypass FDA rules

This site doesn’t allow embedding inside another page — open it in a new tab. Your Weird rating still works from the top bar.

Open source